Nexia Biotechnologies Inc Company Profile

17:31 EDT 24th May 2017 | BioPortfolio

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (, a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.


P.O. BOX 187Branch Jean-Talon
H1S 2Z2


Phone: 514.586.3942
Fax: 514.371.7880

News Articles [160 Associated News Articles listed on BioPortfolio]

Mount Tam Biotechnologies, Inc., to present at Bio CEO Investor Conference

NOVATO, CA--(Marketwired - Feb 9, 2017) - Mount Tam Biotechnologies, Inc. ("Mount Tam") ( OTC PINK : MNTM), a company focused on the Read more...

Elanix Biotechnologies: Erfolgreiche Finanzierungsrunde

Elanix Biotechnologies hat eine Kapitalerhöhung erfolgreich abgeschlossen. Insgesamt werden 1,133 Millionen Aktien ausgegeben. Der Bezugspreis je Aktie liegt bei 4,20 Euro. Somit kommen brutto 4,76.....

Ethrog Biotechnologies iBlot Invitrogen Dry Blotter Gel Transfer System

C $158.17End Date: Monday Apr-10-2017 12:36:52 EDTBuy It Now for only: C $158.17Buy It Now | Add to watch list Biotech365 : Ethrog Biotechnologies iBlot Invitrogen Dry Blotter Gel Transfer System...

Lion Biotechnologies to Present at Upcoming Investor Conferences in March

SAN CARLOS, CA--(Marketwired - February 27, 2017) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (...

Lion Biotechnologies Harnesses TIL Technology to Attack Cancers

ArticleImmunotherapy is one of the biggest things in oncology at the moment and San Francisco-based Lion Biotechnologies Inc., is pushing ahead using tumor-infiltrating lymphocytes (TIL) to destroy so...

Adaptive Biotechnologies, Amgen partner to develop sequencing-based ALL assay

Adaptive Biotechnologies has partnered with biopharmaceutical firm Amgen to advance the development of clonoSEQ assay in acute lymphoblastic leukemia (ALL).

Lion Biotechnologies to partner with MD Anderson on TIL cancer drugs

Lion Biotechnologies entered a multiyear strategic alliance with the University of Texas MD Anderson Cancer Center to conduct -More- 

Elanix Biotechnologies kündigt Kapitalerhöhung an

Noch im Januar will Elanix Biotechnologies einen Beschluss zur Durchführung einer Kapitalerhöhung treffen. Das Potsdamer Unternehmen will die Maßnahme so strukturieren, "dass sie nach deutschen Rec...

Drugs and Medications [0 Results]


PubMed Articles [20 Associated PubMed Articles listed on BioPortfolio]

Maintaining US Leadership in Emerging Biotechnologies to Grow the Economy of the Future.

Stigma, gay men and biomedical prevention: the challenges and opportunities of a rapidly changing HIV prevention landscape.

Improvements in biomedical technologies, combined with changing social attitudes to sexual minorities, provide new opportunities for HIV prevention among gay and other men who have sex with men (GMSM)...

Sourdough-Based Biotechnologies for the Production of Gluten-Free Foods.

Sourdough fermentation, a traditional biotechnology for making leavened baked goods, was almost completely replaced by the use of baker's yeast and chemical leavening agents in the last century. Recen...

Optimization of protocols for Iberian red deer (Cervus elaphus hispanicus) sperm handling before sex sorting by flow cytometry.

Currently, sperm reproductive biotechnologies such as sex sorting and cryopreservation are undoubtedly valuable tools for improving the economic and biological efficiency of red deer production system...

Sharpening the cutting edge: additional considerations for the UK debates on embryonic interventions for mitochondrial diseases.

In October 2015 the UK enacted legislation to permit the clinical use of two cutting edge germline-altering, IVF-based embryonic techniques: pronuclear transfer and maternal spindle transfer (PNT and ...

Clinical Trials [0 Results]


Companies [104 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc.,, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Open Therapeutics

Open Therapeutics ( is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Nexia Biotechnologies Inc" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record